Skip to content

Clinical trials

Phase 4 Thrombosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Phase: Phase 4 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20091
20151
20181
20191
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Not yet recruiting1
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Calgary2
Alexion Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec1
Hamilton Health Sciences Corporation1
Helsinki University Central Hospital1
Nova Scotia Health Authority1
Ottawa Heart Institute Research Corporation1
Ross Leighton1
Sunnybrook Health Sciences Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis13
Thromboembolism5
Venous Thrombosis3
Hemorrhage2
Myocardial Infarction2
Stroke2
Venous Thromboembolism2
Acute Coronary Syndrome1
Anemia1
Arteriovenous Fistula1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.